Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2002
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen
Richard J Klasa, Ralph M Meyer, Chaim Shustik, et al.
Plos One
|
April 5, 2013
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials
Benjamin Djulbegovic, Ambuj Kumar, Branko Miladinovic, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
Anca Prica, Annette E Hay, Michael Crump, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
Annette E Hay, Nicole Mittmann, Michael Crump, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant
A Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Transfusion
|
June 27, 2002
A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets
Nancy M Heddle, Morris A Blajchman, Ralph M Meyer, et al.
Leukemia & Lymphoma
|
June 9, 2016
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12<sup/>
Tara Baetz, Bingshu E Chen, Stephen Couban, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 19, 2015
Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U)
Edward Chow, Carlo DeAngelis, Bingshu E Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2015
Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study
Rena Buckstein, Graeme Fraser, Matthew Cheung, et al.
British Journal of Haematology
|
October 11, 2014
Thalidomide-prednisone maintenance following autologous stem cell transplant for multiple myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10
Michael J Kovacs, Gwynivere A Davies, Judy-Anne W Chapman, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2002
Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen
Richard J Klasa, Ralph M Meyer, Chaim Shustik, et al.
Plos One
|
April 5, 2013
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials
Benjamin Djulbegovic, Ambuj Kumar, Branko Miladinovic, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial
Anca Prica, Annette E Hay, Michael Crump, et al.
Current Oncology (Toronto, Ont.)
|
April 3, 2021
A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data
Annette E Hay, Nicole Mittmann, Michael Crump, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant
A Keith Stewart, Christine I Chen, Kang Howson-Jan, et al.
Transfusion
|
June 27, 2002
A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets
Nancy M Heddle, Morris A Blajchman, Ralph M Meyer, et al.
Leukemia & Lymphoma
|
June 9, 2016
Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12<sup/>
Tara Baetz, Bingshu E Chen, Stephen Couban, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 19, 2015
Effect of re-irradiation for painful bone metastases on urinary markers of osteoclast activity (NCIC CTG SC.20U)
Edward Chow, Carlo DeAngelis, Bingshu E Chen, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2015
Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study
Rena Buckstein, Graeme Fraser, Matthew Cheung, et al.
British Journal of Haematology
|
October 11, 2014
Thalidomide-prednisone maintenance following autologous stem cell transplant for multiple myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10
Michael J Kovacs, Gwynivere A Davies, Judy-Anne W Chapman, et al.
Page
of 8